Skip to content
Prevest Denpro logo

Prevest Denpro

543363 BSE
₹400.00

Close ·

P/E
21.28
View as Markdown
MCP
Close 4 Nov 2026 ₹400.00 −114.50 −22.3% 1Y
Start ₹514.50

Key Fundamentals

SMEHealthcare Equipment & SuppliesHealthcare

Price-based figures at the close · EPS basis: Standalone · TTM

ROCE
24.90%
Debt to Equity
0.00
EPS (TTM)
₹18.80
Book Value
₹103.97
Market Cap
—
P/E (TTM)
21.28
P/B
3.85
ROE
18.50%
Dividend Yield
0.25%
EBITDA
₹29.60 Cr
52W High
₹523.95
52W Low
₹318.15

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

Overall score

59 Good

Data confidence 98/100

Category scores

Quality
81
Strong
Returns, margins, earnings quality 22% weight
Valuation
46
Average
Cheap vs sector & own history 24% weight
Growth
59
Good
Sales & profit trajectory 9% weight
Financial Health
86
Strong
Solvency, leverage, coverage 9% weight
Momentum
50
Average
Trend strength, vol-adjusted 12% weight
Ownership
50
Average
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

1
  • Company is almost debt free.

No weaknesses listed

Technical Indicators

Technical signals: verdict and indicator counts
GroupSignalBearishNeutralBullish
OverallBullish469
OscillatorsBearish261
Moving AveragesStrong Bullish208

Key readings

RSI (14)
58.39
Neutral
MACD (12,26,9)
0.94
Bullish
SMA (50)
387.43
Bullish
SMA (200)
404.82
Bearish

As of

Growth Rate

From the financial statements below. 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.

Revenue

Revenue growth by window
5Y+20.79%
3Y+12.92%
1Y+14.29%
TTM+15.16%

Net profit

Net profit growth by window
5Y+24.57%
3Y+9.49%
1Y+16.67%
TTM+17.62%

Operating cash flow

Operating cash flow growth by window
5Y+12.20%
3Y+16.96%
1Y+6.67%
TTM—

TTM: Reported once a year, so there is no trailing-twelve-month figure.

Operating margin· change in pp

Operating margin growth by window
5Y+3.97 pp
3Y−3.89 pp
1Y+1.19 pp
TTM+0.38 pp

Revenue by year

Revenue by year, ₹ crore
Mar 2019₹19.00 Cr
Mar 2020₹23.00 Cr
Mar 2021₹28.00 Cr
Mar 2022₹38.00 Cr
Mar 2023₹50.00 Cr
Mar 2024₹56.00 Cr
Mar 2025₹63.00 Cr
Mar 2026₹72.00 Cr

Net profit by year

Net profit by year, ₹ crore
Mar 2019₹3.00 Cr
Mar 2020₹5.00 Cr
Mar 2021₹7.00 Cr
Mar 2022₹12.00 Cr
Mar 2023₹16.00 Cr
Mar 2024₹16.00 Cr
Mar 2025₹18.00 Cr
Mar 2026₹21.00 Cr

Quarterly Results

₹ Cr
543363 quarterly results, ₹ crore
Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
13.39
13.18
13.62
16.24
13.34
16.26
14.93
18.54
15.72
18.66
18.37
18.9
19.44
Expenses
8.43
8.68
9.15
10.36
8.85
10.45
9.79
11.91
10.19
11.96
12.15
11.81
12.55
Operating Profit
4.96
4.5
4.47
5.88
4.49
5.81
5.14
6.63
5.53
6.7
6.22
7.09
6.89
OPM %
37.04%
34.14%
32.82%
36.21%
33.66%
35.73%
34.43%
35.76%
35.18%
35.91%
33.86%
37.51%
35.44%
Other Income
0.61
0.74
0.68
0.84
0.86
1.07
1.1
1.08
1.17
1.2
1.16
1.46
1.33
Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
Depreciation
0.17
0.22
0.42
0.46
0.48
0.47
0.48
0.47
0.49
0.5
0.51
0.5
0.52
PBT
5.4
5.02
4.73
6.26
4.87
6.41
5.76
7.24
6.21
7.4
6.87
8.05
7.7
Tax %
24.26%
25.7%
23.26%
25.56%
25.26%
24.49%
22.4%
27.49%
25.44%
24.73%
25.04%
24.72%
24.94%
Net Profit
4.08
3.74
3.64
4.66
3.65
4.84
4.46
5.25
4.63
5.57
5.15
6.06
5.78
EPS (₹)
3.4
3.12
3.03
3.88
3.04
4.03
3.72
4.37
3.86
4.64
4.29
5.05
4.82

Profit & Loss

₹ Cr
543363 profit and loss, annual, ₹ crore
Particulars Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
19
23
28
38
50
56
63
72
75
Expenses
15
17
19
23
30
36
41
46
48
Operating Profit
4
5
9
15
20
20
22
26
27
OPM %
20%
23%
32%
40%
40%
36%
35%
36%
36%
Other Income
0
2
1
2
2
3
4
5
5
Interest
0
0
0
0
0
0
0
0
0
Depreciation
0
0
0
1
1
1
2
2
2
PBT
4
6
9
16
21
21
24
29
30
Tax %
20%
20%
23%
28%
25%
25%
25%
25%
—
Net Profit
3
5
7
12
16
16
18
21
23
EPS (₹)
3.22
5.39
8.19
9.64
13.09
13.43
15.16
17.85
18.8
Div. Payout %
0%
0%
0%
0%
8%
7%
7%
6%
—

Balance Sheet

₹ Cr
543363 balance sheet, annual, ₹ crore
Particulars Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
0.29
0.29
0.29
12
12
12
12
12
Reserves
10
15
22
45
61
77
94
114
Borrowings
1
2
1
1
0
0
0
0
Other Liabilities
4
4
7
6
6
6
7
8
Total Liabilities
15
21
31
64
79
95
113
134
Fixed Assets
5
5
5
7
7
27
27
27
CWIP
0
0
2
5
17
0
0
0
Investments
0
0
0
1
1
2
5
9
Other Assets
10
16
23
52
53
66
81
98
Total Assets
15
21
31
64
79
95
113
134

Cash Flow

₹ Cr
543363 cash flow, annual, ₹ crore
Particulars Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
3
5
9
7
10
11
15
16
Investing
−1
−1
−2
−4
−12
−2
−2
−2
Financing
0
0
−1
23
−1
0
−1
−1
Net Cash Flow
2
4
6
26
−3
9
12
12
Free Cash Flow
2
4
7
2
−3
8
13
14
CFO/EBITDA
96
115
118
75
79
80
94
87

Ratios

543363 financial ratios, annual
Particulars Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
46
35
48
22
31
53
45
45
Inventory Days
28
59
59
122
139
162
208
235
Days Payable
70
72
181
61
40
34
42
54
Cash Conversion Cycle
4
22
−74
83
130
181
211
227
Working Capital Days
10
20
3
41
64
80
81
89
ROCE %
—
45%
47%
40%
32%
27%
25%
25%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Prevest Denpro insights

59 extracted metrics across FY19–FY27.

Shareholding Pattern

As of Sep 2026

  • Promoters 73.60%
  • Public 16.90%
  • Others 8.05%
  • DIIs 0.79%
  • FIIs 0.65%

No promoter shares pledged as of 14 Oct 2026

Change vs previous quarter

Not shown for some quarters: Others. Not available separately for this quarter: the shareholding filing gives Public and Others as one figure, shown under Public, so Others is left blank rather than estimated.

Documents

Frequently Asked Questions about Prevest Denpro

What does Prevest Denpro Ltd do?
Incorporated in 2000, Prevest DenPro Limited is into development and manufacturing of dental materials used for diagnosis, prevention and treatment of dental conditions. Company is heavily export-oriented.
Where is Prevest Denpro Ltd (PREVEST) listed?
Prevest Denpro Ltd trades under code 543363 on the BSE.
Which sector does Prevest Denpro Ltd belong to?
Prevest Denpro Ltd is classified under the Healthcare sector, in the Medical Equipment industry.
What is the PE ratio of Prevest Denpro Ltd?
Prevest Denpro Ltd trades at a PE ratio of 21.28 as of 4 Nov 2026, on earnings per share of ₹18.8, against a book value of ₹103.97 per share.
What is the 52-week high and low of Prevest Denpro Ltd?
Over the last 52 weeks Prevest Denpro Ltd has traded between ₹318.15 and ₹523.95 as of 4 Nov 2026.
Does Prevest Denpro Ltd pay dividends?
Prevest Denpro Ltd has a dividend yield of 0.25%.
What is the Return on Equity (ROE) of Prevest Denpro Ltd?
Prevest Denpro Ltd reported a return on equity of 18.50%. Its debt-to-equity ratio is 0.00.

Company Information

Incorporated in 2000, Prevest DenPro Limited is into development and manufacturing of dental materials used for diagnosis, prevention and treatment of dental conditions. Company is heavily export-oriented.

Website prevestdenpro.com
Listed 27 Sep 2021
Face Value ₹10

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/543363.md for Prevest Denpro Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Healthcare Equipment stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month